Literature DB >> 19428884

Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling.

J Schulze-Horsel1, M Schulze, G Agalaridis, Y Genzel, U Reichl.   

Abstract

Cell culture-based influenza vaccine manufacturing is of growing importance. Depending on virus strains, differences in infection dynamics, virus-induced apoptosis, cell lysis and virus yields are observed. Comparatively little is known concerning details of virus-host cell interaction on a cellular level and virus spreading in a population of cells in bioreactors. In this study, the infection of MDCK cells with different influenza A virus strains in lab-scale microcarrier culture was investigated by flow cytometry. Together with the infection status of cells, virus-induced apoptosis was monitored. A mathematical model has been formulated to describe changes in the concentration of uninfected and infected adherent cells, dynamics of virus particle release (infectious virions, hemagglutinin content), and the time course of the percentage composition of the cell population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428884     DOI: 10.1016/j.vaccine.2009.02.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes.

Authors:  Emma Petiot; Amal El-Wajgali; Geoffrey Esteban; Cécile Gény; Hervé Pinton; Annie Marc
Journal:  Cytotechnology       Date:  2012-02-25       Impact factor: 2.058

2.  Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.

Authors:  Hui Zeng; Claudia Pappas; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 4.  Influenza A virus infection kinetics: quantitative data and models.

Authors:  Amber M Smith; Alan S Perelson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

5.  Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation.

Authors:  Mitsuko Fukuhara; Shingo Iwami; Kei Sato; Yorihiro Nishimura; Hiroyuki Shimizu; Kazuyuki Aihara; Yoshio Koyanagi
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling.

Authors:  Joachim B Ritter; Aljoscha S Wahl; Susann Freund; Yvonne Genzel; Udo Reichl
Journal:  BMC Syst Biol       Date:  2010-05-13

7.  Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.

Authors:  Emma Petiot; Danielle Jacob; Stephane Lanthier; Verena Lohr; Sven Ansorge; Amine A Kamen
Journal:  BMC Biotechnol       Date:  2011-09-01       Impact factor: 2.563

8.  Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics.

Authors:  Amber M Smith; Frederick R Adler; Julie L McAuley; Ryan N Gutenkunst; Ruy M Ribeiro; Jonathan A McCullers; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2011-02-17       Impact factor: 4.475

9.  Identifying viral parameters from in vitro cell cultures.

Authors:  Shingo Iwami; Kei Sato; Rob J De Boer; Kazuyuki Aihara; Tomoyuki Miura; Yoshio Koyanagi
Journal:  Front Microbiol       Date:  2012-09-04       Impact factor: 5.640

10.  Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load.

Authors:  Stephen M Petrie; Teagan Guarnaccia; Karen L Laurie; Aeron C Hurt; Jodie McVernon; James M McCaw
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.